Correlation Between Shenzhen Mindray and New China

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Mindray and New China at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Mindray and New China into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Mindray Bio Medical and New China Life, you can compare the effects of market volatilities on Shenzhen Mindray and New China and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Mindray with a short position of New China. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Mindray and New China.

Diversification Opportunities for Shenzhen Mindray and New China

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Shenzhen and New is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Mindray Bio Medical and New China Life in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New China Life and Shenzhen Mindray is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Mindray Bio Medical are associated (or correlated) with New China. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New China Life has no effect on the direction of Shenzhen Mindray i.e., Shenzhen Mindray and New China go up and down completely randomly.

Pair Corralation between Shenzhen Mindray and New China

Assuming the 90 days trading horizon Shenzhen Mindray Bio Medical is expected to under-perform the New China. But the stock apears to be less risky and, when comparing its historical volatility, Shenzhen Mindray Bio Medical is 1.6 times less risky than New China. The stock trades about -0.39 of its potential returns per unit of risk. The New China Life is currently generating about -0.25 of returns per unit of risk over similar time horizon. If you would invest  4,953  in New China Life on October 15, 2024 and sell it today you would lose (452.00) from holding New China Life or give up 9.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Shenzhen Mindray Bio Medical  vs.  New China Life

 Performance 
       Timeline  
Shenzhen Mindray Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shenzhen Mindray Bio Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
New China Life 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days New China Life has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, New China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shenzhen Mindray and New China Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Mindray and New China

The main advantage of trading using opposite Shenzhen Mindray and New China positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Mindray position performs unexpectedly, New China can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New China will offset losses from the drop in New China's long position.
The idea behind Shenzhen Mindray Bio Medical and New China Life pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins